Clinical trial
Adjunctive Treatment for Decreasing Symptoms of Schizophrenia
NCT00222235 · University of Maryland, Baltimore, Other · Completed
Key facts
| NCT number | NCT00222235 |
|---|---|
| Title | Adjunctive Treatment for Decreasing Symptoms of Schizophrenia |
| Official title | Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST) |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH The Zucker Hillside Hospital Nathan Kline Institute for Psychiatric Research University of California, Los Angeles Sarah Herzog Hospital University of… |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | d-cycloserine, glycine, placebo |
| Enrollment | 240 |
| Start date | Jan 1, 2000 |
| Primary completion | Jun 1, 2004 |
| Completion | Jun 1, 2004 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 20, 2019 |
| Countries | Israel, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: